Abstract
In this chapter I will discuss the role of matching for the HLA-DR antigens in clinical renal transplantation and the effects of pregraft HLA-DR antibodies on renal allograft outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahern AT, Artruc SB, Delia Pelle P, Cosimi AB, Russell PS, Colvin RB, Fuller TC (1982) Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation 33:103–106
Albrechtsen D, Flatmark A, Jervell J, Solheim B, Thorsby E (1978) HLA-DR antigen matching in cadaver renal transplantation. Lancet 1:825
Albrechtsen D, Moen T, Flatmark A, Halvorsen S, Jakobsen A, Jervell J, Solheim BG, Thorsby E (1981) Influence of HLA-A, B, C, D, and DR matching in renal transplantation. Transplant Proc 13:924–929
Albrechtsen D, Bondevik H, Flatmark A, Halvorsen S, Jakobsen A, Jervell J, Moen T, Solheim BG, Sodal G, Thorsby E (1982) HLA matching in first cadaveric renal transplantation in Norway 1969–1981. Transplant Proc 14:182–184
Albrechtsen D, Moen T, Thorsby E (1983) HLA matching in clinical transplantation. Transplant Proc 15:1120–1123
Ayoub G, Terasaki PI (1982) HLA-DR matching in multicenter, singletyping laboratory data. Transplantation 33:515–517
Ayoub G, Park MS, Terasaki PI, Iwaki Y, Opelz G (1980) B cell antibodies and crossmatching. Transplantation 29:227–229
Baldwin WM, Claas FHJ, van Es LA, van Rood JJ (1981) Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. Transplant Proc 13:103– 107
Berg B, Moller E (1981) Immediate rejection of a HLA-A,B compatible, HLA-DR incompatible kidney with a positive donorrecipient B-cell crossmatch. Scand J Urol Nephrol [Suppl] 54:36
Berg B, Groth CG, Lundgren G, Moller E (1982) The impact of HLA-DR matching on the outcome of cadaver kidney transplantation. Transplant Proc 14:178–181
Blank JL, Leo GM, Sollinger HW, Glass NR, Belzer FO (1982) B-warmpositive crossmatch: a contraindication for transplantation in living related transplants undergoing donorspecific transfusion. Transplantation 33:212–213
Bow LM, Schweizer RT, Cho S (1984) Successful renal transplantation after transient warm B cell antibody to donor specific transfusions. Transplantation 37:618–619
Buckingham JM, Geis WP, Giacchino JL, Popli S, Hano JE, Chejfec G, Jonasson O (1979) B-cell directed antibodies and delayed hyperacute rejection: a case report. J Surg Res 27:268–274
Cats S, Terasaki P, Perdue S, Mickey MR (1984) Effect of HLA typing and transfusions on cyclosporinetreated renalallograft recipients. N Engl J Med 311:675–676
Cicciarelli JC, Chia D, Terasaki PI, Barnett EV, Shirahama S (1979) IgM anti-IgM cold lymphocytotoxins to B cells. Transplant Proc 11:1950–1953
Connors SM, Myberg SJ, Dodds K, Carpenter CB, Garovoy MR (1979) Successful renal allograft in the presence of York (Yka) and autologous B-cell antibodies. Transplant Proc 11:1944–1946
Corry RJ, Schulak JA, Goeken NE, Nghiem DD (1985) The effect of HLA, A, B, and DR matching and blood transfusion in first cadaver kidney transplantation. Transplant Proc 17:756–757
Coxe–Gilliland R, Cross DE (1981) Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single centre. Transplant Proc 13:945–948
Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of MHC class II antigens in normal human organs. Transplantation 38:293–298
d’Amaro J, Hendriks GFJ, Persijn GG, van Rood JJ (1985) Influence of sex and ABO blood group on HLA-A,B, and –DR matching in renal transplantation. Transplant Proc 17:758–760
d’Apice AJF, Tait BD (1979) Improved survival and function of renal transplants with positive B cell crossmatches. Transplantation 27:324–328
d’Apice AJF, Sheil AGR, Tait BD, Bashir HV (1984) A prospective randomized trial of matching for HLA-A and B versus HLA-DR in renal transplantation. Transplantation 38:37–41
Deierhoi MH, Ting A, Morris PJ (1983) Successful renal transplantation despite warm B cell antibodies. Transplantation 36:207–209
Dejelo CL, Williams TC (1977) B-cell cross-match in renal transplantation. Lancet 2:241
Dyer PA, Johnson RWG, Mallick NP, Harris R (1983) A single center prospective study showing no benefit of HLA-DR matching between cadaver kidney donors and recipients. Transplant Proc 15:137–138
Etheredge E, Sicard GA, Anderson CB (1979) Increased detection of leukocytotoxic antibodies by thermal discrimination and their influence on renal allograft survival. Transplantation 27:12–17
Ettenger RB, Terasaki PI, Opelz G, Malekzadeh M, Pennisi AJ, Uittenbogaart C, Fine R (1976) Successful renal allografts across a positive cross-match for donor B-lympho-cyte alloantigens. Lancet 2:56–58
Ettenger RB, Jordan S, Fine RN (1981) Autolymphocytotoxic antibodies in patients on dialysis awaiting renal transplantation. Transplantation 32:248–251
Ettenger RB, Jordan SC, Fine RN (1983) Cadaver renal transplant outcome in recipients with autolymphocytotoxic antibodies. Transplantation 35:429–431
Evans PR, Trickett LP, Smith JL, Maclver AG, Tate D, Slapak M (1985) Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium. Br J Exp Pathol 66:79–87
Flechner SM, Kerman RH, van Buren C, Kahan BD (1984) Successful transplantation of cyclosporinetreated haploidentical livingrelated renal recipients without blood transfusions. Transplantation 37:73–76
Fuggle SV, Errasti P, Daar AS, Fabre JW, Ting A, Morris PJ (1983) Localisation of MHC (HLA-ABC and DR) antigens in 46 kidneys. Differences in HLA-DR staining of tubules among kidneys. Transplantation 35:385–390
Goeken NE, Thompson JS, Corry RJ (1981) A 2-year trial of prospective HLA-DR matching. Effects on renal allograft survival and rate of transplantation. Transplantation 32:522–527
Harris KR, Digard NJ, Gosling DC, Gardner B, Campbell MJ, Tate DG, Sharman VL, Slapak M (1985) HLA-DR matching in renal transplant patients on cyclosporine. Transplant Proc 17:42–43
Iwaki Y, Terasaki PI, Park MS, Billing R (1978) Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet 1:1228–1229
Jakobsen BK, Langhoff E, Platz P, Ryder LP, Thaysen JH, Olgaard K, Kristensen JK, Jorgensen HE, Lokkegaard H, Rasmussen F, Sorensen WS, Svejgaard A (1984) The impact of HLA-DR compatibility on cadaver kidney graft survival in a prospective study with special emphasis on the quality of typing. Tissue Antigens 23:94–104
Jeannet M, Bodmer JG, Bodmer WF, Schapira M (1973) Lymphocytotoxic sera associated with the ABO and Lewis red cell blood groups. In: Dausset J, Colombani J (eds) Histocompatibility testing 1972. Munksgaard, Copenhagen, pp 493–499
Jeannet M, Vassalli P, Hufschmid MF (1980) Enhancement of human kidney allografts by cold B lymphocyte cytotoxins. Transplantation 29:174–175
Jeannet M, Benzonana G, Ami I (1981) Donor-specific B and T lymphocyte antibodies and kidney graft survival. Transplantation 31:160–163
Klintmalm G, Brynger H, Flatmark A, Frodin L, Husberg B, Thorsby E, Groth CG (1985) The blood transfusion, DR matching, and mixed lymphocyte culture effects are not seen in cyclosporinetreated transplant recipients. Transplant Proc 17:1026–1031
Lobo PI (1981) Nature of autolymphocytotoxins present in renal hemodialysis patients. Their possible role in controlling alloantibody formation. Transplantation 32:233–237
Lobo PI, Westervelt FB, Rudolf LE (1977) Kidney transplantability across a positive cross–match. Cross–match assays and distribution of B lymphocytes in donor tissues. Lancet 1:925–928
Lobo PI, Westervelt FB, Rudolf LE (1978) Kidney transplantation across positive B and T cell crossmatches. Transplantation 26:84–86
Madsen M, Kissmeyer–Nielsen F, Rasmussen P, Andersen P (1981) Decreased expression of HLA-DR antigens on peripheral blood B lymphocytes during glucocorticoid treatment. Tissue Antigens 17:195–204
Martins–da–Silva B, Vassalli P, Jeannet M (1978) Matching renal grafts. Lancet 1:1047–1048
Moen T, Albrechtsen D, Flatmark A, Jakobsen A, Jervell J, Halvorsen S, Solheim BG, Thorsby E (1980) Importance of HLA-DR matching in cadaveric renal transplantation. A prospective one-center study of 17 transplants. N Engl J Med 303:850–854
Mohanakumar T, Rhodes C, Mendez–Picon G, Goldman M, Moncure C, Lee H (1981a) Renal allograft rejection associated with presensitization to HLA-DR antigens. Transplantation 31:93–95
Mohanakumar T, Waldrep JC, Phibbs M, Mendez-Picon G, Kaplan AM, Lee HM (1981 b) Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 32:61–66
Myberg SJ, Connors CM, Carpenter CB, Garovoy MR (1979) Positive crossmatches due to autoantibodies in livingrelated transplantation. Transplant Proc 11:1954– 1957
Myburgh J A, Smit J A, Maier G, Shapiro M (1977) B-cell cross-match in renal transplantation. Lancet 2:241–242
Neppert J, Nunez G, Stastny P (1984) HLA-A, B, C; -DR; -MB, and SB antigens on unstimulated human endothelial cells. Tissue Antigens 24:40–47
Opelz G (1985) Ninth International Histocompatibility Workshop renal transplant study. In: Albert ED, Baur MP, Mayr WR (eds) Histocompatibility testing 1985. Springer, Berlin Heidelberg New York Tokyo, pp 342–347
Park MS, Terasaki PI, Bernocco D (1977) Autoantibody against B lymphocytes. Lancet 2:465–467
Park MS, Oriol R, Nakata S, Terasaki PI, Ford R, Bernoco D (1979) ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test. Transplant Proc 11:1947–1949
Pellegrino MA, Belvedere M, Pellegrino AG, Ferrone S (1978) B peripheral lymphocytes express more HLA antigens than T peripheral lymphocytes. Transplantation 25:93–95
Persijn GG, Gabb BW, van Leeuwen A, Nagtegal A, Hoogeboom J, van Rood J J (1978) Matching for HLA antigens of A, B, and DR loci in renal transplantation by Euro transplant. Lancet 1:1278–1281
Persijn GG, van Leeuwen A, Parleviet J, Cohen B, Lansbergen Q, d’Amaro J, van Rood J J (1981) Two major factors influencing kidney graft survival in Euro transplant: HLA-DR matching and blood transfusion(s). Transplant Proc 13:150–154
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPher–son K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1–39
Reekers P, Lucassen-Hermans R, Koene RAP, Kunst VAJM (1977) Autolymphocyto-toxic antibodies and kidney transplantation. Lancet 1:1063–1064
Rhodes CL, Goldman MH, Mendez-Picon G, Lee HM, Mohanakumar T (1984) Multiple specificities of B lymphocytereactive antibodies and their significance in renal allograft survival. Transplant Proc 16:1425–1426
Salvatierra O, Amend W, Vincenti F, Potter D, Iwaki Y, Opelz G, Terasaki PI, Duca R, Hanes D, Cochrum KC, Hopper S, Feduska NJ (1981 a) Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Transplant Proc 13:142–149
Salvatierra O, Iwaki Y, Vincenti F, Amend W, Potter D, Opelz G, Terasaki P, Duca R, Hopper S, Feduska N (1981 b) Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions. Transplantation 32:528–531
Shumak KH, Rachewich RA, Crookston MC, Crookston JH (1971) Antigens of the Ii system on lymphocytes. Nature 231:148–149
Soulillou JP, Bignon JD, Hourmant M, Ythier A, Cozian A, Faye R, Lecogic G, Guenel J (1982) Effect of HLA-A,B, and DR typing, pregraft blood transfusions, and positive anti-B lymphocyte cross-matches on kidneygraft survival - a one center prospective study. Transplant Proc 14:187–190
Sutherland DER, Morrow CE, Kaufman D, Fryd DS, Najarian JS, Burke M, Noreen H, Segall M, Bach FH (1983) The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors. Transplantation 36:643–647
Taylor RJ, Andrews W, Rosenthal JT, Carpenter B, Hakala TR (1984) Influence of DR matching in cadaveric renal transplants performed with cyclosporine. Transplantation 38:616–618
Taylor RJ, Andrews W, Rosenthal JT, Carpenter B, Hakala TR (1985) DR matching in cadaveric renal transplantation with cyclosporine. Transplant Proc 17:1194–1196
Ting A, Morris PJ (1977) Renal transplantation and B-cell cross-matches with autoantibodies and alloantibodies. Lancet 2:1095–1097
Ting A, Morris PJ (1978 a) Matching for B-cell antigens of the HLA-DR series in cadaver renal transplantation. Lancet 1:575–577
Ting A, Morris PJ (1978 b) Reactivity of autolymphocytotoxic antibodies from dialysis patients with lymphocytes from chronic lymphocytic leukemia (CLL) patients. Transplantation 25:31–33
Ting A, Morris PJ (1980) Powerful effect of HLA-DR matching on survival of cadaveric renal allografts. Lancet 2:282–285
Ting A, Morris PJ (1981) Positive crossmatch transplants - safe or not? Transplant Proc 13:1544–1546
Ting A, Morris PJ (1983) Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens 21:219–226
Ting A, Morris PJ (1984) The influence of HLA-A,B and -DR matching and pregraft blood transfusions on graft and patient survival after renal transplantation in a single centre. Tissue Antigens 24:256–264
Ting A, Williams KA, Morris PJ (1980) HLA-DR matching and B-cell crossmatching in renal transplantation. Transplant Proc 12:495–501
Vaidya S, Orosz C, Cerilli J, Sommer B, Ferguson R (1984) The clinical significance of donorspecific B cell antibody after donorspecific blood transfusion in renal transplantation. Transplant Proc 16:1447
van Rood, Hendriks GFJ, d’Amaro J, Gratama JW, Jager M, van Es A, Persijn GG (1985) HLA matching, patient survival, and immune response genes in renal transplantation. Transplant Proc 17:681–685
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ting, A. (1986). The Role of HLA Class II Antigens in Clinical Transplantation. In: Solheim, B.G., Møller, E., Ferrone, S. (eds) HLA Class II Antigens. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70367-6_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-70367-6_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-70369-0
Online ISBN: 978-3-642-70367-6
eBook Packages: Springer Book Archive